The protein encoded by this gene is an RNA-binding nuclear protein that is a tumor-rejection antigen. This antigen possesses tumor epitopes capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes in cancer patients and may be useful for specific immunotherapy. This gene product is found to be an important cellular factor for HIV-1 gene expression and viral replication. It also associates transiently with U6 and U4/U6 snRNPs during the recycling phase of the spliceosome cycle. This encoded protein is thought to be involved in the regulation of mRNA splicing.
AU045857 DSAP1 hSART-3 KIAA0156 MGC138188 mKIAA0156 P100 p110 p110 nuclear RNA-binding protein p110(nrb) RP11-13G14 SART3 SART-3 Squamous cell carcinoma antigen recognized by T-cells 3 Tat-interacting protein of 110 kDa TIP110 Tumor-rejection antigen SART3; HIV-1 Tat-interacting protein of 110kDa; hSART-3; p110 nuclear RNA-binding protein; SART-3; squamous cell carcinoma antigen recognized by T cells 3; Squamous cell carcinoma antigen recognized by T-cells 3; Tat-interacting protein of 110 kDa; Tip110
Cat # 17179113
100 µL
Cat # 15504882
100 µL
Cat # 16679774
100 µL
Cat # 13402747
100 µL
Cat # 16526631
100 µL
Cat # 16848054
150 µL
Cat # 16858054
20 µL
Cat # 16186248
50 µL
Cat # 16196248
50 ug
Cat # 16079557
100 ug
Cat # 11326093
100 µg
Searching for an antibody we don't offer? We make custom antibodies for specific targets, species and applications.
More than 18,000 custom antibodies created so far.
Talk To A Specialist NowIf an Invitrogen™ antibody doesn’t perform as described on our website or datasheet, we’ll replace the product at no cost to you, or provide you with a credit for a future purchase.*
Get expert recommendations for common problems or connect directly with an on staff expert for technical assistance related to applications, equipment and general product use.